MB
GH icon

MPM BioImpact’s Guardant Health GH Stock Holding History

MPM BioImpact’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-442,656
Closed -$23M – 44
2025
Q2 		$23M Hold
442,656
– – 3.99% 4
2025
Q1 		$18.9M Sell
442,656
-10,083
-2% -$435K 3.24% 11
2024
Q4 		$13.8M Sell
452,739
-46,431
-9% -$1.31M 1.96% 19
2024
Q3 		$11.5M Sell
499,170
-830
-0.2% -$23.5K 1.72% 20
2024
Q2 		$14.4M Buy
+500,000
New +$11.6M 2.24% 12

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MPM BioImpact's GH Position: Q3 2025 in Review

MPM BioImpact sold out of Guardant Health (GH) in Q3 2025, closing a stake of 442,656 shares — an estimated $23M sold.

MPM BioImpact first reported a position in GH in Q2 2024 and held it in 5 quarters. The position peaked at $23M in Q2 2025. 395 funds tracked by Wall St. Rank hold GH as of Q3 2025.

  • MPM BioImpact reported no remaining Guardant Health position as of Q3 2025 after selling out during the quarter.
  • MPM BioImpact sold 442,656 Guardant Health shares in Q3 2025, an estimated $23M.
  • MPM BioImpact first reported a position in Guardant Health in Q2 2024 and held it in 5 quarters.
  • MPM BioImpact's Guardant Health position peaked at $23M in Q2 2025.
  • 395 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.

Based on MPM BioImpact's 13F filing for Q3 2025, filed 14 Nov 2025.